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doi:10.1016/j.jmii.2011.12.013Background/Purpose: Nontyphoidal Salmonella (NTS) is a crucial pathogen in immunocompro-
mised patients, especially those with connective tissue disease (CTD) and corticosteroid or
immunosuppressant therapy. The aim of this study is to identify the clinical characteristics
and outcomes of patients with CTD and NTS bacteremia, and the clinical variations between
systemic lupus erythematosus (SLE) and other CTDs.
Methods: During a 15-year study period, from 1994 to 2009, NTS bacteremia patients were re-
viewed from the database of clinical microbiology laboratory. Medical records were reviewed
for clinical information and only patients with underlying CTD were included.
Results: From 1994 to 2009, there were 299 patients with NTS bacteremia. Forty-six (15.4%)
patients had certain connective tissue diseases, and SLE was the major CTD, accounting for
73.9% (34) of 46 patients. In comparison with patients without CTD, the patients with CTD were
younger (p < 0.0001), had a predominance of female gender (p < 0.0001), fewer extra-
intestinal focal infections (pZ 0.011), and a lower mortality rate (pZ 0.008). Overall, there
were four fatal cases, accounting for a mortality rate of 8.7% of those afflicted with CTD.
The factors of old age (p< 0.006), shock at presentation (pZ 0.033), acute renal failure
(pZ 0.001), and presence of any extra-intestinal focal infection (p< 0.0001) were associated
with mortality in the univariate analysis.t of Internal Medicine, National Cheng Kung University Hospital, 138 Sheng Li Road, Tainan 70403,
u.edu.tw (W.-C. Ko).
an Society of Microbiology. Published by Elsevier Taiwan LLC. All rights reserved.
Nontyphoidal Salmonella bacteremia in patients with CTD 351Conclusion: Nontyphoidal Salmonella bacteremia causes substantial morbidity and mortality in
patients with connective tissue disease, especially in the elderly population. The aggressive
detection of extra-intestinal infections may be beneficial.
Copyright ª 2012, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Systemic lupus erythematosus (SLE), scleroderma, poly-
myositis, dermatomyositis, rheumatoid arthritis, and Sjog-
ren’s syndrome are a few of the common disease entities of
connective tissue diseases (CTDs).1,2 Steroid and immuno-
suppressive drugs are effective medications for these
diseases. Infection-related morbidity and mortality is
a critical issue for patients because of disease-related
immune dysregulation and an immunosuppressive treat-
ment regimen.3 Nontyphoidal Salmonella (NTS) is one of the
major food-borne pathogens in the world, and may cause
severe and widespread infections, especially in immuno-
compromised patients.4 Infectious diseases may cause
substantial mortality and morbidity in SLE patients.2 SLE is
regarded as the most common underlying disease in patients
with Salmonlla bacteremia.2,5 Self-limited gastroenteritis
and bacteremia, with or without extra-intestinal focal
infections (EFIs), are common clinical presentations of
nontyphoidal salmonellosis. Extra-intestinal focal infections
include infected aortitis, meningitis, pneumonia, soft-tissue
infection, and pyomyositis.6 However, NTS infections in
patients with CTD were rarely reported. Therefore, we
studied the clinical characteristics and clinical outcomes of
the specific patient population.
Materials and methods
A retrospective study was conducted at a medical center in
southern Taiwan. We recruited patients with NTS bacter-
emia, of which the onset was between 1994 and 2009. Only
the first occurrence of NTS bacteremia from each patient
was included. The patients with the underlying disease of
CTD were specifically concerned as the study population.
A number of patients with a broad sense of chronic
inflammatory diseases in an immunosuppressed status, not
traditional CTD but receiving chronic steroid therapy, were
also recruited. The clinical characteristics of patients with
CTD and those without CTD were compared. The patients
with SLE and those with a CTD other than SLE were
compared. Medical records were reviewed for demographic
data, underlying diseases, clinical manifestations, labora-
tory data at admission, microbiological characters, anti-
microbial susceptibility, treatment course, and clinical
outcomes.
Microbiology and antimicrobial susceptibility
The slide agglutination test was used to determine the
serogroups of Salmonella isolates by O antisera (Difco
Laboratories, Detroit, MI, USA). For serogroup C or D isolates,the identification of Salmonella typhi or Salmonella para-
typhi was screened by Vi antisera (BBL, Cockeysville, MD,
USA). For the serogroup C1 isolates, if the citrate test was
negative, such an isolate was reported as Salmonella chol-
eraesuis. The interpretations of antimicrobial susceptibility
were based on the criteria of Clinical and Laboratory Stan-
dards Institute.7
Definitions
Fever was defined as the axillary temperature of  38C.
Shock was defined by a systolic blood pressure of 90 mmHg
or the use of an inotropic agent to maintain blood pressure.
Leukocytosis was defined as a leukocyte count of > 10,000
cells/mm3, and leucopenia < 3000 cells/mm3. Chronic
renal disease was defined as a serum creatinine level of
 1.5 mg/dL. Immunosuppressive therapy was defined as
the receipt of prednisolone at a daily dose of more than
10 mg, a corticosteroid at the equivalent dosage for at least
2 weeks, chemotherapy for malignancy, or an immunosup-
pressive agent. Antimicrobial therapy was regarded as
appropriate if the pathogen was in vitro susceptible to the
agent prescribed within 72 hours after admission. Extra-
intestinal focal infection (EFI) of salmonellosis was
referred to active infection lesions, evidenced by clinical
symptoms and signs, or radiological imaging, such as
computed tomography or ultrasonography.
Statistical analysis
The Statistical Package for the Social Science for Windows
(SPSSWIN; SPSS, Chicago, IL, USA), version 15.0, was used to
conduct the data analysis. Categorical variables were
illustrated as numbers and percentages, and compared by
the Chi-square test or Fisher’s exact test. The continuous
variables were expressed as a median, interquartile range,
and were compared by the Student t test or the Wilcoxon
rank sum test.
Results
Clinical information
During the study period of 1994 to 2009, a total of 299
patients with NTS bacteremia were found, including 46
patients with CTD, and 253 patients without CTD. The
clinical characteristics of 46 adults (‡ 18 years old) with
CTD and NTS bacteremia are shown in Table 1. Female
gender was predominant in patients with CTD, and the
mean age of patients with CTD was younger than those
without CTD. The serogroups of 46 NTS isolates from adults
Table 1 Clinical characteristics of patients with or without connective tissue disease complicated by nontyphoidal Salmonella
bacteremia
Clinical characteristics Case number (%) p valuese
CTD (nZ 46) NonCTD (nZ 253)
SLEc (nZ 34) Othersd (nZ 12) Total (nZ 46)
Female gender 25 (73.5) 9 (75.0) 34 (73.9) 88 (34.8) <0.0001
Age (y) (median, interquartile range) 35(27-43) 58(49-66) 38 (28-53) 65 (51-73) <0.0001
Underlying disease
Atherosclerotic conditions
Diabetes mellitus 11 (32.4) 4 (33.3) 15 (32.6) 75 (29.6) 0.068
Hypertension 6 (17.7) 4 (33.3) 10 (21.7) 83 (32.8) 0.136
Coronary artery disease 1 (2.9) 0 (0) 1 (2.2) 30 (11.9) 0.062
Stroke 1 (2.9) 0 (0) 1 (2.2) 18 (7.1) 0.327
Chronic renal disease 8 (23.5) 4 (33.3) 12 (26.1) 78 (30.8) 0.519
Liver cirrhosis 0 (0) 1 (8.3) 1 (2.2) 36 (14.2) 0.022
Malignancy 0 (0) 1 (8.3) 1 (2.2) 98 (38.7) <0.0001
HIV infectiona 0 (0) 0 (0) 0/43 (0) 18/229 (7.9) 0.087
Serogroups 0.611
B 18 (52.9) 5 (41.7) 23 (50) 115 (45.5)
C1/C2 9 (26.5)/1 (2.9) 2 (16.7)/1 (8.3) 11 (23.9)/2 (4.3) 66 (26.0)/6 (2.4)
D 6 (17.6) 4 (33.3) 10 (21.7) 61 (24.1)
E 0 (0) 0 (0) 0 (0) 3 (1.2)
Clinical symptoms and signs
Fever 29 (85.2) 10 (83.3) 39 (84.8 185 (73.1) 0.09
Gastrointestinal symptoms 5 (14.7) 2 (16.7) 7 (15.2) 53 (20.9) 0.372
Shock 2 (5.9) 2 (16.7) 4 (8.7) 72 (28.5) 0.005
Acute renal failure 5 (14.7) 4 (33.3) 9 (19.6) 80 (31.5) 0.091
Leukopenia 8 (23.5) 3 (25.0) 11 (23.9) 158 (62.5) 0.032
Leukocytosis 5 (14.7) 6 (50.0) 11 (23.9) 126 (49.8) 0.001
Immunosuppression 31 (96.9) 9 (75.0) 40 (86.9) 58 (22.9) <0.0001
Appropriate treatmentb 19 (55.9) 10 (83) 29 (63.0) 165 (65.2) 0.698
Extra-intestinal focal infections 4 (11.8) 3 (25.0) 7 (15.2) 86 (34.0) 0.011
Mortality 1 (2.9) 3 (25.0) 4 (8.7) 68 (26.9) 0.008
CTDZ connective tissue disease; HIVZ human immunodeficiency virus; SLEZ systemic lupus erythematosus.
a Only 272 patients were tested for human immunodeficiency virus infection.
b Refer to an in vitro active drug prescribed within 72 hours.
c Systemic lupus erythematosus.
d Others mean other CTD, including polymyositis/dermatomyositis (4), rheumatoid arthritis (3), bullous pemphigoid (1), amyotrophic
lateral sclerosis (1), psoriasis (1), erythroderma (1), and Sjo¨gren’s syndrome (1).
e Comparisons between those with or without CTDs.
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group D (10, 21.7%), and group C (2, 28.3%). All serogroup
C1 isolates were S. choleraesuis.
Comparisons of patients with and without CTD,
complicated by NTS bacteremia
Patients with CTD were younger and had fewer metastatic
infections than those without CTD (Table 1). The patients
without CTD commonly had liver cirrhosis (14.2% vs. 2.2%,
pZ 0.022), malignancy (38.7% vs. 2.2%, p< 0.0001), shock
at presentation (28.5% vs. 8.7%, pZ 0.005), and EFI (34%
vs. 15.2%, pZ 0.011). The patients with CTD complicated
by NTS bacteremia had a superior prognosis (mortality rate:
8.7% vs. 26.9%, pZ 0.008).
To explore the potential impact of underlying CTD,
immunocompetent adults without chronic underlying illnessand those with only CTD as the underlying illness were
compared in Table 2. The factors of older age (57.9 vs. 35.8
years; p< 0.0001), more EFI (56.5% vs. 5.6%; pZ 0.001), and
a higher mortality rate (13% vs. 0%, pZ 0.24), were noted in
the immunocompetent patients with NTS bacteremia.
SLE and other CTD patients
The most common disease among the 46 patients with CTD
was SLE (34 patients) (Table 1). As the distinguishing
feature among patients with CTD, females predominated in
patients with SLE and those with other CTD. However, SLE
patients were younger than those with other CTD (36.6 vs.
55.3 years). No significant difference was observed in the
clinical presentations of NTS bacteremia and concurrent
underlying disease, or the development of EFI in both
groups. However, the survival rate of SLE patients with NTS
Table 2 Comparisons of the patients with connective tissue disease only and immunocompetent patients complicated by
nontyphoidal Salmonella bacteremia
Clinical characteristics Case number (%)a p values
NonCTD (nZ 23) CTDb (nZ 18)
Female gender 6 (26.1) 11 (61.1) 0.02
Age (y) (median, interquartile range) 63 (48e72) 32.5 (27.5e41.0) <0.0001
Clinical symptoms and signs
Fever 22 (95.6) 14 (77.8) 0.15
Gastrointestinal symptoms 6 (26.1) 3 (16.7) 0.71
Shock 4 (17.4) 1 (5.6) 0.36
Acute renal failure 4 (17.4) 3 (16.7) 1.00
Leukopenia 2 (8.7) 3 (16.7) 0.64
Leukocytosis 13 (56.5) 3 (16.7) 0.009
Immunosuppression 2 (8.7) 17 (94.4) <0.0001
Extra-intestinal focal infection 13 (56.5) 1 (5.6) 0.001
Primary bacteremia 10 (43.5) 17 (94.4) 0.001
Appropriate treatment 16 (69.6) 12 (66.7) 0.84
Mortality 3 (13.0) 0 (0) 0.24
CTDZ connective tissue disease.
a Only patients tested for human immunodeficiency virus infection were included.
b CTD included systemic lupus erythematosus (15) and dermatomyositis (3).
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other CTD was 75% (9/12).
Fatal cases of CTD and NTS bacteremia
Four fatal cases occurred during our study (Table 3). The
mean age was 61.8 years (range 43e76 years). Three of theTable 3 Clinical summary of four adult deaths with connectiv
bacteremia
Case no. 1 2
Connective tissue
disease
Systemic lupus
erythematosus
Bullous pemphigoid
Age (y) 43 76
Gender Female Female
Infection site Pneumonia Left forearm celluli
subscutaneous absc
Salmonella serogroup B D
Comorbidity Diabetes
mellitus
Liver cirrhosis
Immunosuppressiona Yes No
Clinical symptoms and signs
Fever Yes No
Shock No No
Acute renal failure Yes Yes
Thrombocytopenia No No
Leukocytosis Yes No
Hospitalization before
death (d)
30 5
Appropriate antibiotic
within 72 h
Yes Yes
Surgical intervention d No
a Receipt of prednisolone daily dose more than 10 mg or corticoster
malignancy, or immunosuppressive agent.four patients received immunosuppressant therapy. All
patients had another underlying disease, and EFI, such as
pneumonia (one case) or skeletal soft-tissue infections
(three cases), and received appropriate antibiotics within
72 hours. However, three patients presenting with acute
renal failure, shock and thrombocytopenia died within 5
days after the onset of NTS bacteremia.e tissue disease complicated with nontyphoidal Salmonella
3 4
Dermatomyositis Rheumatoid
arthritis
63 65
Female Female
tes and
ess
Right thigh necrotizing
fasciitis and pyomyositis
Psoas pyomyositis
B B
Diabetes mellitus, chronic
pulmonary disease, chronic
kidney disease
Diabetes mellitus,
chronic kidney
disease
Yes Yes
Yes No
Yes Yes
Yes Yes
Yes Yes
No Yes
2 3
Yes Yes
No No
oid at the equivalent dosage for at least 2 wk, chemotherapy for
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Nontyphoidal salmonellosis is a food-borne infection that
occurs in patients throughout the world, especially in
immunocompromised patients. The common risk factors of
salmonellosis include old age, malignancy, diabetes, rheu-
matological disorders and immunosuppressive therapy.3,8,9
Among our patients without CTD, the elderly, and adults
with underlying liver cirrhosis or malignancy, are the
susceptible population for NTS bacteremia. A characteristic
higher mortality rate and more extra-intestinal focal
infections in patients without CTD may be, at least
partially, related to the presence of underlying medical
illness.
The common underlying disease in the patients pre-
senting with Salmonella bacteremia is SLE.10 As young age
is the specific character of patients with SLE, we observed
a higher incidence of shock, acute renal failure, and extra-
intestinal infections in patients with other CTD. The
patients with SLE are less likely to receive appropriate
antimicrobial therapy within the initial 72 hours as the
initial presentations of NTS bacteremia are easily over-
lapped by the flare-up of the disease activity of SLE, such as
lupus fever, leucopenia or thrombocytopenia. The
mortality rate of patients with other CTD is higher than
those with SLE, even though 83% of these patients received
an appropriate antimicrobial agent within 72 hours. It is
assumed that the host factor, most likely age, plays an
important role in the clinical outcome of adults with CTD
complicated with NTS bacteremia.
Graciela et al (2006) reported that the common species
in SLE patients with Salmonella bacteremia were S. chol-
eraesuis, Salmonella enteritidis, Salmonella typhimurium
and Salmonella arizona.2 The groups B, D and C were the
three major serogroups among the serogroup distribution
of NTS obtained from SLE patients in Taiwan.10 In our
study, the most common NTS bacteremic isolates are the
serogroups B, C and D, regardless of the patient
subgroups, without CTD, with SLE, or with other CTD. This
serogroup distribution reflects the frequent exposure to
certain serogroups in the community or the variable
invasiveness of these serogroups. Further serovar or
serotype determination of these bacteremic isolates may
be useful in the delineation of the cause of the predomi-
nance of serogroup B.
In a systemic review of infection-related mortality in
patients with CTD, the overall median mortality rate was
20% with a range of 2.1e79%. In major types of CTD, the
mortality rates were similar, 4.7% in SLE, 6.5% in rheuma-
toid arthritis and 5% in polymyositis or dermatomyositis.11
In our study, the crude mortality rate was 8.7% in patients
with CTD, 2.9% in SLE, and 25% in other CTD. However, the
limited case number and heterogeneous population in the
types of CTD between different studies make the compar-
isons of clinical outcomes difficult.
Severe soft-tissue infections with abscess formation or
necrotizing fasciitis may cause high mortality, especially in
immunocompromised patients.12 Two studies reported that
necrotizing fasciitis caused a mortality rate of 20e50% in
patients with underlying SLE or rheumatic diseases.13,14 The
causative pathogens of necrotizing fasciitis among patientswith underlying rheumatic diseases are Streptococcus
pyogenes, Staphylococcus aureus, Pseudomonas fluo-
rescens, Morganella morganii, Aeromonas caviae and
Escherichia coli.14 Few severe soft-tissue infections, caused
by NTS species, were reported in patients with CTD. In our
study, three of the four fatal cases with CTDs complicated
with NTS bacteremia had soft-tissue infections, including
psoas muscle abscess, necrotizing fasciitis, and cellulitis
with abscess formation. Therefore, physicians should
consider NTS as one of the causative pathogens of invasive
soft-tissue infections in patients with CTD.
There are a number of limitations in our study. The
case number of patients with CTD is small, and not all
patients fulfilled the traditional criteria of CTD. However,
the vast majority of our case patients had SLE, poly-
myositis/dermatomyositis, rheumatoid arthritis or Sjo¨g-
ren’s syndrome, accounting for 91.3% (42/46) of those
categorized as having CTD. A number of patients were not
tested for HIV infection, and it is likely that the impact of
underlying HIV infection was underestimated, especially
those grouped as being immunocompetent.
In summary, nontyphoidal Salmonella bacteremia causes
substantial morbidity and mortality in patients with connec-
tive tissue disease, especially in the elderly population. The
aggressive detection of extra-intestinal infections may be
beneficial, and soft-tissue infections may be associated with
in a grave prognosis.References
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